KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories Posts Behind the Scenes Look into the Laboratory R&D Processes for Creating Recombinant Spider Silk

Kraig Biocraft Laboratories Posts Behind the Scenes Look into the Laboratory R&D Processes for Creating Recombinant Spider Silk

ANN ARBOR, Mich., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces the release of the second behind the scenes look into its recombinant spider silk production operations. This video brings the viewer inside the laboratories at its R&D facility in the U.S. and its quality control lab at its production facility in Vietnam.

This video tour edition highlights the laboratory facilities and the team of dedicated researchers and scientists creating and commercializing the world's first cost-effective and eco-responsible spider silk.

"Our research and quality assurance teams are leading the way, creating and commercializing some of the most amazing materials on earth," said Company COO Jon Rice.

Interested viewers can find the video at or through the Company's YouTube Channel , where they can subscribe to be notified of future video releases in this series.

In upcoming video releases, the Company expects to bring viewers along for tours inside the rearing and breeding operations and the opportunity to meet some of the team creating tomorrow's super fibers.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to .

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a fully reporting biotechnology company, is a developer of genetically engineered spider silk-based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could," "will" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495



EN
04/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Sil...

24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Silkworms Make History at Scale Kraig Labs Cracks the Spider Silk Code DENVER, Feb. 11, 2026 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the undisputed global leader in the development and commercialization of spider silk, is entering a new phase of commercial scale-up as it accelerates production to meet growing demand from global brands. Kraig Labs u...

 PRESS RELEASE

Kraig Biocraft Laboratories Poised for Explosive Spider Silk Productio...

Kraig Biocraft Laboratories Poised for Explosive Spider Silk Production Growth 2026 Production Plan Set for a Record 10 Metric Tons of Recombinant Spider Silk Cocoon Per Month ANN ARBOR, Mich., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced its 2026 production plan that will drive explosive growth and establish a new global benchmark for spider silk manufacturing. Kraig's technology is built upon the use of modified silkworms to produce recombinant ...

 PRESS RELEASE

Control the Stack, Control the Future: The New Era of Supply-Chain Pow...

Control the Stack, Control the Future: The New Era of Supply-Chain Power DENVER, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Innovation still rules, but ownership of the entire supply-chain pipeline is becoming the next biggest strategic advantage in today’s markets. From raw inputs to final delivery, companies that control their supply chains are increasingly the ones dictating price, pace, and profit. SpaceX’s acquisition of xAI is the latest and, perhaps boldest, proof of that thesis. When SpaceX announced it had formally acquired xAI, Elon Musk framed it not as a merger, but as a turning point...

 PRESS RELEASE

The Real Ironman Economy: How AI, Superfibers, and Defense Tech Could ...

The Real Ironman Economy: How AI, Superfibers, and Defense Tech Could Theoretically Converge DENVER, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Recent reports that Palantir Technologies (NASDAQ: PLTR) has been tapped by President Trump to deploy AI systems to hunt fraud, likened in headlines to an AI “Ironman suit”, have reignited interest in how far advanced technology can really go. While the phrase is metaphorical, the underlying idea is very real: software, materials, and hardware are converging to augment human capability in ways that once sounded like science fiction. So, what if Palantir, ...

 PRESS RELEASE

Kraig Biocraft Laboratories Rings in the New Year with the Most Ambiti...

Kraig Biocraft Laboratories Rings in the New Year with the Most Ambitious Genetic Engineering Program in its History ANN ARBOR, Mich., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it is entering the new year with the implementation of the most ambitious and advanced genetic engineering initiative ever undertaken by the Company. The focus of this project is to dramatically increase strength and elasticity beyond anything ever seen in the area of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch